about
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reu...
Read More
2.63
0.10
(3.95%)
18,863
XNAS Volume
XNAS 24 Dec, 2025 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
NLS Pharmaceutics Ltd Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..